Published in

American Association for the Advancement of Science, Science Translational Medicine, 339(8), 2016

DOI: 10.1126/scitranslmed.aad3099

Links

Tools

Export citation

Search in Google Scholar

The caspase-8 inhibitor emricasan combines with the SMAC mimetic birinapant to induce necroptosis and treat acute myeloid leukemia

This paper is made freely available by the publisher.
This paper is made freely available by the publisher.

Full text: Download

Green circle
Preprint: archiving allowed
Green circle
Postprint: archiving allowed
Red circle
Published version: archiving forbidden
Data provided by SHERPA/RoMEO

Abstract

The combination of a SMAC mimetic and a caspase inhibitor kills AML cells by inducing necroptosis.